Skip to main content
Top
Published in: BMC Gastroenterology 1/2023

Open Access 01-12-2023 | Ulcerative Colitis | Research

Identification and immunological characterization of cuproptosis-related molecular clusters in ulcerative colitis

Authors: Yunfei Pu, Xianzhi Meng, Zhichen Zou

Published in: BMC Gastroenterology | Issue 1/2023

Login to get access

Abstract

Background

Ulcerative colitis is one of the two main forms of inflammatory bowel disease. Cuproptosis is reported to be a novel mode of cell death.

Methods

We examined clusters of cuproptosis related genes and immune cell infiltration molecules in 86 ulcerative colitis samples from the GSE179285 dataset. We identified the differentially expressed genes according to the clustering method, and the performance of the SVM model, the random forest model, the generalized linear model, and the limit gradient enhancement model were compared, and then the optimal machine model was selected. To assess the accuracy of the learning predictions, the nomogram and the calibration curve and decision curve analyses showed that the subtypes of ulcerative colitis have been accurately predicted.

Results

Significant cuproptosis-related genes and immune response cells were detected between the ulcerative colitis and control groups. Two cuproptosis-associated molecular clusters were identified. Immune infiltration analysis indicated that different clusters exhibited significant heterogeneity. The immune scores for Cluster2 were elevated. Both the residual error and root mean square error of the random forest machine model had clinical significance. There was a clear correlation between the differentially expressed genes in cluster 2 and the response of immune cells. The nomogram and the calibration curve and decision curve analyses showed that the subtypes of ulcerative colitis had sufficient accuracy.

Conclusion

We examined the complex relationship between cuproptosis and ulcerative colitis in a systematic manner. To estimate the likelihood that each subtype of cuproptosis will occur in ulcerative colitis patients and their disease outcome, we developed a promising prediction model.
Literature
1.
go back to reference Mulder DJ, Noble AJ, Justinich CJ, Duffin JM. A tale of two diseases: the history of inflammatory bowel disease. J Crohns Colitis. 2014;8(5):341–8.PubMed Mulder DJ, Noble AJ, Justinich CJ, Duffin JM. A tale of two diseases: the history of inflammatory bowel disease. J Crohns Colitis. 2014;8(5):341–8.PubMed
2.
go back to reference Buse Balci S, Aktas G. A comprehensive review of the role of hemogram derived inflammatory markers in gastrointestinal conditions. Iran J Colorectal Res. 2022;10(3):75–86. Buse Balci S, Aktas G. A comprehensive review of the role of hemogram derived inflammatory markers in gastrointestinal conditions. Iran J Colorectal Res. 2022;10(3):75–86.
3.
go back to reference Aktaş G, Duman TT, Atak B, et al. Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters. Fam Med Prim Care Rev. 2020;22(2):107–10. Aktaş G, Duman TT, Atak B, et al. Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters. Fam Med Prim Care Rev. 2020;22(2):107–10.
4.
go back to reference Posul E, Yilmaz B, Aktas G, Kurt M. Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis? Wien Klin Wochenschr. 2015;127(7–8):262–5.PubMed Posul E, Yilmaz B, Aktas G, Kurt M. Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis? Wien Klin Wochenschr. 2015;127(7–8):262–5.PubMed
5.
go back to reference Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–78.PubMed Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–78.PubMed
6.
go back to reference Jones G-R, Lyons M, Plevris N, et al. IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology. Gut. 2019;68(11):1953–60.PubMed Jones G-R, Lyons M, Plevris N, et al. IBD prevalence in Lothian, Scotland, derived by capture-recapture methodology. Gut. 2019;68(11):1953–60.PubMed
7.
go back to reference Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–7.PubMed Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12(12):720–7.PubMed
8.
go back to reference Conley S, Proctor DD, Jeon S, Sandler RS, Redeker NS. Symptom clusters in adults with inflammatory bowel disease. Res Nurs Health. 2017;40(5):424–34.PubMedPubMedCentral Conley S, Proctor DD, Jeon S, Sandler RS, Redeker NS. Symptom clusters in adults with inflammatory bowel disease. Res Nurs Health. 2017;40(5):424–34.PubMedPubMedCentral
9.
go back to reference Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use Med Care. 1996;34(9):924–30.PubMed Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia. Disability and health-care use Med Care. 1996;34(9):924–30.PubMed
10.
go back to reference Nocerino A, Nguyen A, Agrawal M, et al. Fatigue in inflammatory bowel diseases: etiologies and management. Adv Ther. 2020;37(1):97–112.PubMed Nocerino A, Nguyen A, Agrawal M, et al. Fatigue in inflammatory bowel diseases: etiologies and management. Adv Ther. 2020;37(1):97–112.PubMed
11.
go back to reference Cohen RD, Yu AP, Wu EQ, et al. Systematic review: the costs of ulcerative colitis in Western countries. Aliment Pharmacol Ther. 2010;31(7):693–707.PubMed Cohen RD, Yu AP, Wu EQ, et al. Systematic review: the costs of ulcerative colitis in Western countries. Aliment Pharmacol Ther. 2010;31(7):693–707.PubMed
12.
go back to reference Abraham BP, Kane S. Fecal markers: calprotectin and lactoferrin. Gastroenterol Clin North Am. 2012;41(2):483–95.PubMed Abraham BP, Kane S. Fecal markers: calprotectin and lactoferrin. Gastroenterol Clin North Am. 2012;41(2):483–95.PubMed
13.
go back to reference Ng SC, Bernstein CN, Vatn MH, et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62(4):630–49.PubMed Ng SC, Bernstein CN, Vatn MH, et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62(4):630–49.PubMed
14.
go back to reference Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44(4):431–40.PubMed Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009;44(4):431–40.PubMed
15.
go back to reference Ho G-T, Chiam P, Drummond H, et al. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther. 2006;24(2):319–30.PubMed Ho G-T, Chiam P, Drummond H, et al. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther. 2006;24(2):319–30.PubMed
16.
go back to reference Farrell RJ. Biologics beyond Anti-TNF Agents for Ulcerative Colitis - Efficacy, Safety, and Cost? N Engl J Med. 2019;381(13):1279–81.PubMed Farrell RJ. Biologics beyond Anti-TNF Agents for Ulcerative Colitis - Efficacy, Safety, and Cost? N Engl J Med. 2019;381(13):1279–81.PubMed
17.
go back to reference Singh S, George J, Boland BS, Vande Casteele N, Sandborn WJ. Primary non-response to tumor necrosis factor antagonists is associated with inferior response to second-line biologics in patients with inflammatory bowel diseases: a systematic review and meta-analysis. J Crohns Colitis. 2018;12(6):635–43.PubMedPubMedCentral Singh S, George J, Boland BS, Vande Casteele N, Sandborn WJ. Primary non-response to tumor necrosis factor antagonists is associated with inferior response to second-line biologics in patients with inflammatory bowel diseases: a systematic review and meta-analysis. J Crohns Colitis. 2018;12(6):635–43.PubMedPubMedCentral
18.
go back to reference Kirsner JB. Historical aspects of inflammatory bowel disease. J Clin Gastroenterol. 1988;10(3):286–97.PubMed Kirsner JB. Historical aspects of inflammatory bowel disease. J Clin Gastroenterol. 1988;10(3):286–97.PubMed
19.
go back to reference Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254–61.PubMedPubMedCentral Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254–61.PubMedPubMedCentral
20.
go back to reference Tang D, Chen X, Kroemer G. Cuproptosis: a copper-triggered modality of mitochondrial cell death. Cell Res. 2022;32(5):417–8.PubMedPubMedCentral Tang D, Chen X, Kroemer G. Cuproptosis: a copper-triggered modality of mitochondrial cell death. Cell Res. 2022;32(5):417–8.PubMedPubMedCentral
21.
go back to reference Cobine PA, Brady DC. Cuproptosis: Cellular and molecular mechanisms underlying copper-induced cell death. Mol Cell. 2022;82(10):1786–7.PubMed Cobine PA, Brady DC. Cuproptosis: Cellular and molecular mechanisms underlying copper-induced cell death. Mol Cell. 2022;82(10):1786–7.PubMed
22.
go back to reference Tsukumo S-I, Yasutomo K. Regulation of CD8+ T cells and antitumor immunity by notch signaling. Front Immunol. 2018;9:101.PubMedPubMedCentral Tsukumo S-I, Yasutomo K. Regulation of CD8+ T cells and antitumor immunity by notch signaling. Front Immunol. 2018;9:101.PubMedPubMedCentral
23.
go back to reference Garis M, Garrett-Sinha LA. Notch signaling in B cell immune responses. Front Immunol. 2020;11: 609324.PubMed Garis M, Garrett-Sinha LA. Notch signaling in B cell immune responses. Front Immunol. 2020;11: 609324.PubMed
24.
go back to reference Zhao J, Guo S, Schrodi SJ, He D. Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: implication, prospects, and perspectives. Front Immunol. 2022;13: 930278.PubMedPubMedCentral Zhao J, Guo S, Schrodi SJ, He D. Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: implication, prospects, and perspectives. Front Immunol. 2022;13: 930278.PubMedPubMedCentral
25.
go back to reference Yu L, Shen H, Ren X, et al. Multi-omics analysis reveals the interaction between the complement system and the coagulation cascade in the development of endometriosis. Sci Rep. 2021;11(1):11926.PubMedPubMedCentral Yu L, Shen H, Ren X, et al. Multi-omics analysis reveals the interaction between the complement system and the coagulation cascade in the development of endometriosis. Sci Rep. 2021;11(1):11926.PubMedPubMedCentral
26.
go back to reference Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 2007;23(14):1846–7.PubMed Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics. 2007;23(14):1846–7.PubMed
27.
go back to reference Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–7.PubMedPubMedCentral Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–7.PubMedPubMedCentral
28.
go back to reference Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–3.PubMedPubMedCentral Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–3.PubMedPubMedCentral
29.
go back to reference Wu D, Yin Z, Ji Y, et al. Identification of novel autophagy-related lncRNAs associated with a poor prognosis of colon adenocarcinoma through bioinformatics analysis. Sci Rep. 2021;11(1):8069.PubMedPubMedCentral Wu D, Yin Z, Ji Y, et al. Identification of novel autophagy-related lncRNAs associated with a poor prognosis of colon adenocarcinoma through bioinformatics analysis. Sci Rep. 2021;11(1):8069.PubMedPubMedCentral
30.
go back to reference Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.PubMedPubMedCentral Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.PubMedPubMedCentral
31.
32.
go back to reference Gold C, Sollich P. Model selection for support vector machine classification. Neurocomputing. 2003;55(1):221–49. Gold C, Sollich P. Model selection for support vector machine classification. Neurocomputing. 2003;55(1):221–49.
33.
go back to reference Nelder JA, Wedderburn RWM. Generalized Linear Models. Journal of the Royal Statistical Society: Series A (General). 1972;135(3):370–84. Nelder JA, Wedderburn RWM. Generalized Linear Models. Journal of the Royal Statistical Society: Series A (General). 1972;135(3):370–84.
34.
go back to reference Zhang X, Lu Z, Ren X, et al. Genetic comprehension of organophosphate flame retardants, an emerging threat to prostate cancer. Ecotoxicol Environ Saf. 2021;223: 112589.PubMed Zhang X, Lu Z, Ren X, et al. Genetic comprehension of organophosphate flame retardants, an emerging threat to prostate cancer. Ecotoxicol Environ Saf. 2021;223: 112589.PubMed
35.
go back to reference Liu Y, Wang J, Li L, et al. AC010973.2 promotes cell proliferation and is one of six stemness-related genes that predict overall survival of renal clear cell carcinoma. Sci Rep. 2022;12(1):4272.PubMedPubMedCentral Liu Y, Wang J, Li L, et al. AC010973.2 promotes cell proliferation and is one of six stemness-related genes that predict overall survival of renal clear cell carcinoma. Sci Rep. 2022;12(1):4272.PubMedPubMedCentral
36.
go back to reference Bastida G, Mínguez A, Nos P, Moret-Tatay I. Immunoepigenetic regulation of inflammatory bowel disease: current insights into novel epigenetic modulations of the systemic immune response. Genes (Basel). 2023;14(3):554.PubMed Bastida G, Mínguez A, Nos P, Moret-Tatay I. Immunoepigenetic regulation of inflammatory bowel disease: current insights into novel epigenetic modulations of the systemic immune response. Genes (Basel). 2023;14(3):554.PubMed
37.
go back to reference Li F, Ouyang J, Chen Z, et al. Nanomedicine for T-cell mediated immunotherapy. Adv Mater. 2023;25: e2301770. Li F, Ouyang J, Chen Z, et al. Nanomedicine for T-cell mediated immunotherapy. Adv Mater. 2023;25: e2301770.
38.
go back to reference Shao M, Yuan F, Liu J, Luo H. Mast cell specific receptor mrgprb2 regulating experimental colitis is associated with the microbiota-gut-brain axis. J Inflamm Res. 2022;15:6137–51.PubMedPubMedCentral Shao M, Yuan F, Liu J, Luo H. Mast cell specific receptor mrgprb2 regulating experimental colitis is associated with the microbiota-gut-brain axis. J Inflamm Res. 2022;15:6137–51.PubMedPubMedCentral
39.
go back to reference Tang S, Zhong W, Li T, Li Y, Song G. Isochlorogenic acid A alleviates dextran sulfate sodium-induced ulcerative colitis in mice through STAT3/NF-кB pathway. Int Immunopharmacol. 2023;118: 109989.PubMed Tang S, Zhong W, Li T, Li Y, Song G. Isochlorogenic acid A alleviates dextran sulfate sodium-induced ulcerative colitis in mice through STAT3/NF-кB pathway. Int Immunopharmacol. 2023;118: 109989.PubMed
40.
go back to reference Falahati F, Westman E, Simmons A. Multivariate data analysis and machine learning in Alzheimer’s disease with a focus on structural magnetic resonance imaging. J Alzheimers Dis. 2014;41(3):685–708.PubMed Falahati F, Westman E, Simmons A. Multivariate data analysis and machine learning in Alzheimer’s disease with a focus on structural magnetic resonance imaging. J Alzheimers Dis. 2014;41(3):685–708.PubMed
41.
go back to reference Zhang L, Li Z, Skrzypczynska KM, et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell. 2020;181(2):442-459.e29.PubMed Zhang L, Li Z, Skrzypczynska KM, et al. Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer. Cell. 2020;181(2):442-459.e29.PubMed
42.
go back to reference Lai L, Shin GY, Qiu H. The role of cell cycle regulators in cell survival-dual functions of cyclin-dependent kinase 20 and p21Cip1/Waf1. Int J Mol Sci. 2020;21(22):8504.PubMedPubMedCentral Lai L, Shin GY, Qiu H. The role of cell cycle regulators in cell survival-dual functions of cyclin-dependent kinase 20 and p21Cip1/Waf1. Int J Mol Sci. 2020;21(22):8504.PubMedPubMedCentral
43.
go back to reference Satoda Y, Noguchi T, Fujii T, et al. BROMI/TBC1D32 together with CCRK/CDK20 and FAM149B1/JBTS36 contributes to intraflagellar transport turnaround involving ICK/CILK1. Mol Biol Cell. 2022;33(9):ar79.PubMedPubMedCentral Satoda Y, Noguchi T, Fujii T, et al. BROMI/TBC1D32 together with CCRK/CDK20 and FAM149B1/JBTS36 contributes to intraflagellar transport turnaround involving ICK/CILK1. Mol Biol Cell. 2022;33(9):ar79.PubMedPubMedCentral
44.
go back to reference Chen K, Zeng Z, Ma C, Dang Y, Zhang H. Commentary on: screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers. Biosci Rep. 2021;41(12):BSR20211096.PubMedPubMedCentral Chen K, Zeng Z, Ma C, Dang Y, Zhang H. Commentary on: screening of immunosuppressive cells from colorectal adenocarcinoma and identification of prognostic markers. Biosci Rep. 2021;41(12):BSR20211096.PubMedPubMedCentral
45.
go back to reference Aschtgen M-S, Bernard CS, De Bentzmann S, Lloubès R, Cascales E. SciN is an outer membrane lipoprotein required for type VI secretion in enteroaggregative Escherichia coli. J Bacteriol. 2008;190(22):7523–31.PubMedPubMedCentral Aschtgen M-S, Bernard CS, De Bentzmann S, Lloubès R, Cascales E. SciN is an outer membrane lipoprotein required for type VI secretion in enteroaggregative Escherichia coli. J Bacteriol. 2008;190(22):7523–31.PubMedPubMedCentral
46.
go back to reference Salewski I, Henne J, Engster L, et al. CDK4/6 blockade provides an alternative approach for treatment of mismatch-repair deficient tumors. Oncoimmunology. 2022;11(1):2094583.PubMedPubMedCentral Salewski I, Henne J, Engster L, et al. CDK4/6 blockade provides an alternative approach for treatment of mismatch-repair deficient tumors. Oncoimmunology. 2022;11(1):2094583.PubMedPubMedCentral
47.
go back to reference Artemaki PI, Papatsirou M, Boti MA, et al. Revised exon structure of l-DOPA Decarboxylase (DDC) reveals novel splice variants associated with colorectal cancer progression. Int J Mol Sci. 2020;21(22):8568.PubMedPubMedCentral Artemaki PI, Papatsirou M, Boti MA, et al. Revised exon structure of l-DOPA Decarboxylase (DDC) reveals novel splice variants associated with colorectal cancer progression. Int J Mol Sci. 2020;21(22):8568.PubMedPubMedCentral
Metadata
Title
Identification and immunological characterization of cuproptosis-related molecular clusters in ulcerative colitis
Authors
Yunfei Pu
Xianzhi Meng
Zhichen Zou
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2023
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-023-02831-2

Other articles of this Issue 1/2023

BMC Gastroenterology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.